Clinical Trial Update: A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 study of RO5093151 in ocular hypertension and open-angle glaucoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• RO5093151

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hypertension, Glaucoma, Open-Angle | Phase 2 | Status: COMPLETED